Overview

Iodixanol in Multidetector-Row Computed Tomography-Coronary Angiography (MDCT-CA)

Status:
Completed
Trial end date:
1969-12-31
Target enrollment:
Participant gender:
Summary
Image quality in coronary artery computed tomography is influenced by the heart rate variation during the examination. The purpose of this clinical trial is to investigate the change in heart rate following injection of a contrast medium called Visipaqueâ„¢ (iodixanol). Image quality and diagnostic quality of the examination will be evaluated.
Phase:
Phase 4
Details
Lead Sponsor:
GE Healthcare